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ABSTRACT
Recently, there has been a sharp rise in the use of cannabis products in the United
States of America. This is largely due to decriminalization and legalization of marijuana
across many states. However, marijuana remains illegal on the federal level because it
contains the psychoactive component, Δ9-tetrahydrocannabinol (THC). THC is currently
listed as a schedule I drug by Drug Enforcement Agent (DEA), meaning there is no accepted
medical use, but it has a high potential for abuse. Therefore, cannabis products such as hemp
oil sold in the United States cannot a concentration greater than 0.3% THC.
The goal of this research project is to examine whether 5 commercial hemp oil
products have less than the allowed THC concentration and determine the concentration of
cannabidiol (CBD) via gas chromatography (GC) with flame ionization detector (FID) and
mass selective detector (MSD). This research project described several experimental
challenges of chemical analysis of CBD and THC in hemp oil via GC and development of
experimental methods to quantify target compounds. Some experimental challenges
described in this project are septum bleeding, degradation of target compounds, and
decarboxylation of precursors. By the use of improved analytical method, CBD and THC in
five hemp oil products were analyzed. It was found that CBD concentrations were
significantly lower than advertised on the product label, and no traces of THC were detected
from all samples.
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I.

Introduction and Background

1.1

Motivation and Objective
The use of hemp and marijuana in the United States can be traced back to the 1600’s.

Hemp in particular was a highly coveted agriculture because of its versatility. It was often
used to make clothing, rope and sails during those times. Marijuana was more widely used
for medicinal purposes, such as pain relief, appetite stimulation, and counter opioid
withdrawal. For nearly a century, marijuana was an ingredient used in a variety of medicine
until the early 20th century. In 1910, Mexican immigrants sought refuge from the Mexican
revolution and introduced recreational marijuana to the United States. As a result, Americans
began to associate marijuana with the influx of Mexican immigrants. This led to growing
racism in the United States and eventually the illegalization of cannabis.
The Marijuana Tax Laws of 1937 was the first step to criminalizing cannabis
nationwide. It placed taxes on the possession, sale and trading of any cannabis products in the
United States; this included both hemp and marijuana. During this time, fear of drugs was
becoming more prevalent in the United States, and President Nixon declared a “war on
drugs.” The declaration imposed harsher drug laws, such as mandatory prison sentences, to
mitigate public fear. He also created the Controlled Substance Act (CSA) of 1970, which
allowed the federal government to regulate controlled substances [1]. The CSA separated
known drugs into five different classification schedules. Depending on which classification
schedule the drug was placed under, it would regulate how the substance was distributed,
manufactured, and used. The CSA categorized the drugs based on their potential for abuse
and addiction and whether they have legitimate medical use. Drugs, such as heroin, that have
a high potential for abuse with no accepted medical use would be classified as a schedule I
drugs. Whereas, Robutussin, a common cough syrup, would be classified as a schedule IV
drug with low potential for abuse and accepted medical usage.
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Following the development of the CSA, cannabis, hemp and marijuana, were
immediately deemed as a schedule I drug. This made it difficult for scientists and doctors to
study the plant for medicinal purposes. It was not until 1996 when California became the first
state to legalize marijuana for medical use and shortly afterwards, Colorado became the first
state to legalize recreational use of marijuana. Finally, in 2018, hemp was officially removed
from the CSA via the Hemp Farming Act of 2018. However, to this day, marijuana remains
listed as a schedule I drug.
As of 2021, 14 states have legalized the recreational use of marijuana and 16 states
have decriminalized its use (Figure 1). Over 20 states allow for the sale of cannabis for
medicinal use, whether through injection, inhalation or prescription medicine. Marijuana
remains illegal under the federal law, but state marijuana laws are continuously changing.
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Figure 1. Legal status for marijuana across the United States. Obtained from Marijuana
Policy Project.

It is a common misconception that marijuana and hemp are two different species of
plant. However, they are in fact just two different names for Cannabis sativa L., a flowering
plant in the Cannabaceae family. Although science does not differentiate between
“marijuana” and “hemp,” the law separates the two based on the level of
tetrahydrocannabinol (THC) present. Federal law defines hemp as “the plant Cannabis sativa
L. that contains 0.3% or less THC content by dry weight,” [2] whereas marijuana is any
cannabis that contains over 0.3% THC content.
The main reason for the two plants to be differentiated legally, is because
consumption of THC to a certain amount can cause psychological effects. Cannabis sativa L.
is comprised of over 100 cannabinoids, but THC is the primary psychoactive component.
Routine marijuana smokers have shown signs of “subtle working memory impairment,”

3

mood swings and an altered sense of time [3]. Working memory refers to the ability to store
and manipulate the information to produce a response. For instance, an individual under the
influence of marijuana would have more difficulty reciting a particular sentence backwards
compared to a sober individual.
As more states legalize and decriminalize marijuana, many companies are eager to
introduce new innovational CBD and hemp products into the market. Since Colorado
legalized recreational marijuana in 2012, CBD products have saturated the market in various
forms including oils, edibles, vaporizers, creams etc. It is now very common to see these
products sold all across the U.S. and even for online purchase. Currently, in New York, CBD
products derived from marijuana are considered illegal. However, CBD products derived
from hemp can be sold as long as they follow state regulations. The Department of Health
allows for the “intermediate sales of hemp extract containing up to 3.0% THC…provided that
the sale is between licensed processors in New York State” [10]. However, hemp extract
products are not required to be labeled with the concentration of CBD in the product. In
comparison, products extracted from marijuana are legally obligated to disclose the amount
of milligrams of THC and CBD per serving [10].
The main focus of this study was to determine if five commercial hemp oil follow
federal and New York state regulations; in addition to whether the amount of CBD was
reflective of the amount printed on the product label. This study also addressed the challenges
faced when performing chemical analysis of CBD and THC via gas chromatography.
In the current study, both GC-FID and GC-MSD were utilized to analyze CBD
compound in hemp oil samples. The reasoning behind using both GC-FID and GC-MSD was
because the GC-FID produces a stronger signal and is more sensitive for quantitative
analysis. While the GC-MSD provides qualitative information, such as chemical structure of
the compound [11]. The GC-MSD is also useful in identifying any unknown compound that
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may be present in the hemp oil sample matrix. With the allowance of up to 0.3% THC, this
quantitative experiment served to determine if there were any evidence of THC violation and
whether the concentration printed on the label refers to CBD concentration.
1.2

Endocannabinoid and Phytocannabinoid
In the past, cannabinoids were thought to be naturally occurring compounds derived

solely from the Cannabis sativa L. plant. However, in 1990, the cannabinoid 1 (CB1)
receptor in the human body was discovered by Allyn Howlett and William Devane. Shortly
after, the endocannabinoid system was discovered in 1992. The finding of the
Endocannabinoid system was significant because it implied that the human body produces its
own cannabinoids similar to the ones produced by cannabis. Cannabinoids produced by
plants are called phytocannibinoids and cannabinoids produced by mammals are called
endocannabinoids. Phytocannabinoids react to the endocannabinoid receptors in the body [4]
and could be the reasoning behind why THC and CBD derived from marijuana have such a
strong effect on humans. The main purpose of the endocannabinoid system is to help the
body maintain homeostasis. There are two main cannabinoid receptors, CB1 and cannabinoid
receptor 2 (CB2). CB1 is most abundant in the Central Nervous System (CNS), whereas
CB2 is primarily located on immunological tissues. Since these cannabinoid receptors are
ubiquitous throughout the human body, it explains why smoking marijuana can affect
cognition, mood, pain, appetite, and nausea. Since the human body already utilizes
endocannabinoids to maintain different bodily functions, it naturally follows that
phytocannabinoid will also affect the same bodily functions. Although there are many other
cannabinoid receptors, CB1 and CB2 receptors are the most studied.
1.3

Mechanism of THC and CBD
CBD is an isomer of THC, with both sharing the same molecular weight of 314
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g/mol. THC is the primary psychoactive component in Cannabis sativa L. and is responsible
for the ‘high’ people experience when smoking marijuana. In comparison, CBD does not
produce any psychoactive effect. This could be due to the differences in chemical structure
and how they interact with the receptors in the body. Although they are both comprised of the
same molecular formula, CBD has a hydroxyl group and THC has a cyclic ring (Figure 2).
The broken ring in CBD allows it to bend in the 3-dimension, whereas THC has a more rigid
and flat structure.

Figure 2. Chemical structure of THC and CBD.
There are currently 113 known phytocannabinoids, but CBD and THC are by far the
two most studied phytocannabinoid. Cannabinoids are composed of a phenol group and a 5carbon chain. When cannabis is consumed, CBD and THC binds to either CB1 or CB2.
However, THC has a higher affinity to bind to CB1, which is located primarily in the central
nervous system. Since THC is a partial agonist, it stimulates the CB1 receptors to produce
psychological effects. This response includes that overwhelming euphoric feeling marijuana
users get addicted to. One possible explanation why CBD does not exhibit the same
psychotropic effect as THC is that CBD is a negative allosteric modulator [4]. A negative
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allosteric modulator alters the shape of the receptor by binding to a secondary site on the
receptor, thus making it difficult for CB1 agonist, such as THC, to produce a psychotropic
response. Since CBD does not actually bind or stimulate the CB1 receptor, it could explain
why cannabis users tend to not experience the same ‘high’ when consuming CBD-only
products. The exact mechanism for how THC and CBD interacts with the body is still the
subject of ongoing research.

1.4

Analysis of Cannabis Products
Before cannabis products are allowed to enter the market, they must go through a

series of tests prior to approval. Cannabis product testing differs from state to state, but the
four most common tests are potency testing, residual solvent testing, heavy metal testing and
lastly, pesticide testing. Potency testing is the reporting of the dry weight of THC and CBD in
the product. This is typically done using high performance liquid chromatography (HPLC) or
gas chromatography-mass spectrometry (GC-MS) [6]. Residual solvent tests for any residual
solvent that may have been left over in the product during the extraction process. Ethanol,
methanol and other organic solvents are the most commonly used solvents in the extraction
process for CBD. Testing for these residual solvents is critical in preventing risk of alcohol
toxicity and death. Presently, the U.S. Food and Drug Administration (FDA) has established
a limit of no more than 200 ppm of ethanol or methanol to be present in any consumable
product [7].
In the same sense, cannabis products also need to be tested for any heavy as exposure
to high concentration of heavy metals can be lethal. Cannabis products may contain traces of
heavy metal because the plant could have taken it in from the soil or fertilizers. Lastly,
pesticide testing screens for the presence of any pesticides that may have ended up in the
products. But which pesticides to screen for varies greatly across the country. For example, in
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California, CBD products must test for 55 different types of pesticides, whereas in Colorado,
it is only required to test for 13 types of pesticides.
1.5

Gas Chromatography
Gas chromatography can be coupled with several detectors, but typically organic

compounds are analyzed using either flame ionization detector (FID) or mass spectrometry
detector (MSD). GC technology started in the 1950’s by Anthony T. James and Archer J. P.
Martin of the National Institute for Medical Research. The technique was later built upon to
accommodate other analytical techniques, such as the mass spectrometry (MS), and
eventually evolved into the GC-MSD. Now, the GC-MSD is commonly used for quick
chemical analysis in forensics, drug analysis, medical labs, and many more.
In general, chromatography is a laboratory technique used to separate different
components of a solution. Once the components are separated, they can be analyzed
individually. Typically, for GC, a sample is injected by a syringe through a septum into a
heated chamber. The septum serves to seal the injection port and prevent any compounds
from leaking out. The heat vaporizes the sample, and the carrier gas pushes the sample into a
capillary column. The analytes are then separated in the capillary column. Separation is
dependent on the size of the analytes and its affinity to the stationary phase. Analytes that are
smaller and have less affinity to the stationary phase will elute faster. Larger analytes with a
higher affinity to the stationary phase, meaning it will interact more with the column, will
elute slower. As the compounds elute from the column, it is detected by the detector.
1.5.1

GC-FID Instrumental Operation
For FID, it detects ions formed through combustion in a hydrogen flame (Figure 3).

As compounds elute from the column, hydrogen mixes with the carrier gas containing the
compounds. A flame is ignited by burning hydrogen, air and the carrier gas. As the analytes
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are burnt by the flame, hydrocarbons will produce ions. These ions are then detected by a
collector that sends signals to be converted into peaks.

Figure 3. Overview of GC-FID analytical instrument.

1.5.2 GC-MSD Instrumental Operation
Similar to the FID, the MSD evaluates the individual compounds that elute out of the
GC column. However, instead of passing through a flame, the analytes are bombarded with
electrons to break them into molecular ions and fragments of these molecular ions (Figure 4).
These ions then travel through a quadruple mass analyzer that filters them based on their size.
A quadruple mass analyzer is made of four parallel rods with a space for the central axis to
allow ions to travel through [8]. Superimposed direct current (DC) and alternate current
(AC) voltages are applied at each opposing pair of electrodes. The DC and AC voltages are
varied linearly while keeping the ratio constant. As ions pass through the oscillating electric
field, they are filtered based on their mass-to-charge ratio (m/z) and only ions with a certain
m/z will pass through the quadruple to be detected. Ions with a m/z outside of the specified
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voltage will not be able to pass through the quadruple, and thus will not be detected [9]. After
passing through the quadruple, the MSD calculates how many of each ion with a particular
mass was present in the sample. This information is presented as mass spectra and
compounds can be identified based on the mass spectra produced.

Figure 4. Overview of GC-MSD analytical instrument.

II.
2.1

Materials and Methods
Reagents and Standards
THC and CBD were purchased from Cerilliant Corporation (Round Rock, Texas

USA) with a 1.000  0.005 mg/mL concentration in methanol (Figure 5). The five
commercial hemp oil samples were purchased on Amazon. Most of the hemp oils came in 30
mL amber bottles and were immediately refrigerated upon receiving. Methanol and
chloroform were purchased from Thermo Fisher. All solvents are HPLC grade.
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Figure 5. Photograph of (a) commercial hemp oil samples and (b) CBD and THC standards
in methanol.
2.2

Collection of Samples
In this study, five hempseed oils samples were purchased and tested. The five brands

of hemp oil being tested were O’rmeas, Hempio, Hemp Techniques, Greenive, and Zatural.
All five hemp oils were sourced from the United States of America. O’rmeas, Hemp
Technique, Greenive and Zatural listed hemp seed oil as their sole ingredient in their product.
Hempio’s ingredient list included hemp seed oil, vitamin A, vitamin E, and vitamin C. The
samples varied from 300 mg to 35,000 mg per bottle according to the label.
2.3

Sample Preparation and Extraction
An external calibration curve was created for both CBD and THC. The stock

solutions were purchased at a concentration of 1.000  0.005 mg/mL (~1000 ppm). The
solutions were then further diluted to 5 ppm, 10 ppm, 50 ppm, 100 ppm, and 250 ppm and
these became the calibration standards. The calibration standards were used to generate the
calibration curve for the GC-FID. The standards were diluted with HPLC-grade methanol.
After the dilutions, 1 µL was injected into the analytical system. Each sample was analyzed
in quadruplicate.
The hemp oil samples were diluted with chloroform because they were not miscible
with methanol. Initially, the hemp oil samples were diluted by a factor of 5; however, two of
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the five samples did not fall within the calibration range. Therefore, they were further diluted
by a factor of 50 as shown in Table 1. Lastly, 1 L aliquot was injected into the GC-FID for
analysis. All solutions were kept in amber bottles and stored in a refrigerator set to - 20 °C.

Table 1. Dilution factors of hemp oil samples.

2.4

Sample

Dilution

Hempio

1:5

Hemp Technique

1:5

O’Rmeas

1:5

Greenive

1:50

Zatural

1:50

Instrumental Parameters
Two distinct gas chromatography (Agilent Technologies 7890A) instruments were

used, one was coupled with the internal FID and the other was coupled with the MSD
(Agilent Technologies 5975C). Both used a 5% phenyl methyl siloxane capillary (HP-5MS)
column and helium was the carrier gas. The GC-FID used a HP-5MS, 30 m × 0.25 mm ×
0.25 m column and the GC-MS used a HP-5MS, 30 m × 0.25 mm × 1 m column. Each
sample was introduced into a heated inlet set to 260 C to ensure the sample was completely
vaporized prior to entering the column. For the GC-MSD, the final temperature of 300 °C
was held for 2 min longer than the GC-FID because the GC-MSD had a slightly thicker
stationary phase compared to the one installed in the GC-FID. The GC’s oven temperatures
were optimized for each instrument to achieve complete separation during the elution phase
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(Table 2-3). Since the GC-MSD had a larger column compared to the GC-FID, the GC-MSD
had a higher flow rate of 2.5 mL/min and a split ratio of 10:1; whereas the GC-FID had a
flow rate of 1.5 mL/min and a split ratio of 25:1. The injection volume for both instruments
were 1 L aliquots. After compounds eluted from the GC column, they were bombarded with
a 70-eV electron bean that fragmented the compounds in the MSD. The quadrupole was set
to 150 C while it sorted out ions before detection. The ions monitored for the GC-MSD were
at m/z 299 and 314 for THC, and m/z 231 and 246 for CBD [12].

Table 2. GC-FID oven temperature.

Temperature (°C)

Rate of Increase (°C/min.)

Hold time (min.)

160 °C

-

1

190 °C

15

1

300°C

20

2

Temperature (°C)

Rate of Increase (°C/min.)

Hold time (min.)

160 °C

-

1

190 °C

15

1

300°C

20

4

Table 3. GC-MSD oven temperature.
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2.5

Septa Experimental Details
Three different septa (Figure 6) were tested at three different inlet temperatures to

determine which septum showed the least amount of bleeding and interference. The three
septa tested were a red septum from Agilent Technologies (inlet septa, general purpose, red
5mm), a teal septum from Restek (Thermolite® septa), and a gray septum from Agilent
Technologies (inlet septa, general purpose, gray 5mm). The experiment was conducted on the
GC-FID (Agilent Technologies 7890A) under the same parameters presented in Table 2.
Each septum was tested at in inlet temperature of 220 °C, 260 °C, and 300 °C. Once a septum
was installed, the method was immediately run to examine septum bleeding effect before
conditioning. This was done to gauge how effective conditioning a septum was in preventing
septum bleeding. All GC measurements were conducted at each of the three inlet temperature
and conditioned for 30 hrs  5 min at 300 °C. The start and end times for conditioning are
shown in Table 4. Following conditioning, each septum was rerun at the three different inlet
temperatures using the same method as before conditioning.
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Figure 6. Photographs of the three septa used in this study.

Table 4. Conditioning timetable for each septum.

Septum

Date and Time Started

Date and Time Ended

Teal

02/10/21 – 6:12 PM

02/11/21 – 12:12 PM

Gray

02/11/21 – 6:05 PM

02/12/21 – 12:06 PM

Red

02/16/21 – 6:41 PM

02/17/21 – 12:46 PM
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III.

Results and Discussion

3.1

Septum Interference
One challenge faced during the analysis of hemp oil via gas chromatography is the

possibility of septum interference or septum bleeding. At high temperatures, the septum
could bleed into the GC column and result in ghost peaks. These peaks on the chromatogram,
but the corresponding compound may not necessarily be present in the sample. These ghost
peaks cause interference during detection and quantification of compounds. Ghost peaks
could also hinder reproducibility of results. One example of how septum bleeding occurs is
volatile organic compounds (VOC) could be trapped in the septum. When running the GC
instrument, the high inlet temperature causes the trapped VOCs to be released from the
septum and bleed into the column, resulting in ghost peaks. Particularly, in the GC-FID, the
capillary columns are very narrow with a typical flow rate of less than 2 mL/min, which
could result in VOCs becoming very concentrated and cause bleeding to be more pronounced
[13]. Another source for ghost peaks is the bleeding of the actual septum material itself. All
septa are comprised of multiple compounds such as silicone oils, long hydrocarbons,
phthalates, etc. At high temperature, these septum material can be released and result in
septum interference [13].
3.1.1 Teal Septum
In order to minimize the effects of septum bleeding, three different septa were tested
to see which septum was most suited for hemp oil analysis. For the teal septum, there were
peaks observed at all three injection port temperatures, regardless of conditioning. Their
respective chromatograms are shown in Figure 7-12. These peaks started to appear around
the 7.5-min mark and persisted until the end of the run time, around 11.5 min. At 220 °C,
there was a significant amount of bleeding prior to conditioning (Figure 7). Figure 8 shows
the chromatogram at 220 °C after conditioning and there were visibly less crowding of peaks.
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This pattern remained constant for the remaining injection port temperatures as well. (Figures
9-12). Comparing the post-conditioning chromatograms, there were the least amount of peak
interference at 260 °C and 300 °C showed the most amount of peak interference.

Teal Septum 220°C Pre-Conditioning
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Figure 7. GC chromatograms of teal septum observed at 220 °C before conditioning.
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Teal Septum 220°C Post-Conditioning
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Figure 8. GC chromatograms of teal septum observed at 220 °C after conditioning.

Teal Septum 260°C Pre-Conditioning
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Figure 9. GC chromatograms of teal septum observed at 260 °C before conditioning.
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Teal Septum 260°C Post-Conditioning
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Figure 10. GC chromatograms of teal septum observed at 260 °C after conditioning.

Teal Septum 300°C Pre-Conditioning
400
350

Signal (a.u.)

300
250
200
150
100
50
0

0

2

4

6

8

10

12

14

Retention Time (min.)

Figure 11. GC chromatograms of teal septum observed at 300 °C before conditioning.
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Figure 12. GC chromatograms of teal septum observed at 300 °C after conditioning.

3.1.2 Gray Septum
In case of the gray septum, there were ghost peaks observed at all three injection port
temperatures, but considerably less compared to the teal septum. The chromatograms for the
gray septum at each inlet temperatures are shown in Figures 13-18. Comparing the preconditioning graphs to its corresponding post-conditioning graphs, there were visibly less
peaks after conditioning at each inlet temperature. After conditioning, septum performance
seems to be equal, where chromatograms had only some small peaks around retention time at
9.5 min.
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Figure 13. GC chromatograms of gray septum observed at 220 °C before conditioning.
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Figure 14. GC chromatograms of gray septum observed at 220 °C after conditioning.
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Figure 15. GC chromatograms of gray septum observed at 260 °C before conditioning.
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Figure 16. GC chromatograms of gray septum observed at 260 °C after conditioning.
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Figure 17. GC chromatograms of gray septum observed at 300 °C before conditioning.
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Figure 18. GC chromatograms of gray septum observed at 300 °C after conditioning.
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3.1.3 Red Septum
Lastly, for the red septum there was not as a significant change between preconditioning and post-conditioning chromatogram at each inlet temperatures. The
chromatograms for the red septum at each of the inlet temperatures are shown in Figures 1924.
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Figure 19. GC chromatograms of red septum observed at 220 °C before conditioning.
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Figure 20. GC chromatograms of red septum observed at 220 °C after conditioning.
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Figure 21. GC chromatograms of red septum observed at 260 °C before conditioning.
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Figure 22. GC chromatograms of red septum observed at 260 °C after conditioning.
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Figure 23. GC chromatograms of red septum observed at 300 °C before conditioning.

26

Red Septum 300°C Post-Conditioning
120

100

Signal (a.u.)

80

60

40

20

0
0

2

4

6

8

10

12

14

Retention Time (min.)

Figure 24. GC chromatograms of red septum observed at 300 °C after conditioning.

3.1.4 Septum Bleeding Results and Discussion
As shown in Figures 7-24, chromatograms remained free from any ghost peaks in all
three septa when oven temperatures were held at 160 °C and 190 °C. However, when oven
temperatures ramped up to > 200 °C, multiple peaks started to appear in the teal and gray
septum before conditioning. Since GC experimental parameters, such as the oven-heating
temperature and carrier gas remained constant for the entirety of the septum test, the observed
peaks were ascribed to septum bleeding. Out of the three septa, the red septum had the least
number of observed peaks at temperatures above 200 °C and the teal septum had the highest
amount. This could be due to the fact Restek Thermolite® septum, has a maximum
temperature of 340 °C, whereas the Agilent general purpose septum has a maximum
temperature of 400 °C. All three septa showed visibly less bleeding after conditioning for 30
hrs. As a result of this test, the most suitable septum for testing hemp oil samples was
determined to be the red septum and needed to be conditioned prior to running the samples.
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In all of the chromatograms, there was a rise in baseline after the GC oven
temperature began to ramp up to 300 °C around the 6 min mark. The rise in baseline could be
attributed to possible column bleeding of cyclic siloxane or any oxygen trapped in the phase
that was not fully purged during conditioning. As temperatures ramp up, the stationary phase
can be susceptible to bleeding and detected by the GC-FID. Another possible explanation for
the rising baseline is that oxygen was not fully purged during conditioning, meaning the
carrier gas was not allowed to flow through the column long enough prior to running the
samples. This could result in further phase oxidation as the oven temperature ramps up and
contribute in rising baseline [14]. Nonetheless, the rise in baseline does not interfere with the
results of the septa experiment because column bleeding is different from septum bleeding.
Septum bleeding results in distinct peaks as seen in Figure 15 rather than a steady incline as
seen in Figure 23.
3.2

Test for Decarboxylation of CBDA
Another issue researchers must keep in mind when quantifying CBD via GC, is

decarboxylation [15]. Cannabidiolic acid (CBDA) and tetrahydrocannabinolic acid (THCA)
are the most abundant cannabinoids found in the cannabis plants. Hence, it would not be
surprising to find traces of CBDA and THCA in cannabis products such as CBD and hemp
oil. When CBDA and THCA are exposed to high heat, it undergoes decarboxylation and the
compounds are converted to CBD and THC, respectively. Decarboxylation is a chemical
reaction that removes a carboxyl group and produces carbon dioxide as a biproduct. When
samples are injected into the GC instrument, the high inlet temperature causes CBDA and
THCA in the sample to decarboxylate and their products are detected in the chromatogram.
Therefore, when quantifying CBD in the hemp oil samples, it includes the total concentration
of CBD, including any CBDA that was decarboxylated from the high injection temperature.
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For the purpose of proving decarboxylation occurred, salicylic acid was injected into
the GC instrument. At the time of the experiment, CBDA and THCA were unavailable for
purchase, subsequently salicylic acid was used instead to mimic the decarboxylation of
CBDA. Similar to CBDA, salicylic acid also contains a carboxyl group that can be
decarboxylated. When salicylic acid is decarboxylated, it produces phenol and carbon
dioxide. Looking at the chromatogram of salicylic acid (Figure 25), there are two significant
peaks observed at 6.9 and 11.8 min. The peak with the stronger signal at 11.8 min was
identified to be salicylic acid and the peak at 6.9 min was suspected to be phenol. In order to
confirm the peak corresponded to phenol, phenol was injected into the GC-FID using the
same method to test salicylic acid (Figure 26). Since GC-FID only generates retention time, a
positive identification of a compound is only possible by confirming the known retention
time of the desired compound.
The chromatogram for phenol revealed a strong peak at 6.9 min, which matches the
same retention time of the unknown peak in salicylic acid. Comparing the two
chromatograms, it proved salicylic acid underwent decarboxylation because when only
salicylic acid was injected, there was a positive confirmation for the presence of phenol in the
sample. This experiment confirmed that decarboxylation can occur due to the high
temperatures required for GC analysis.
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Figure 25. GC-FID for salicylic acid.
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Figure 26. GC-FID for phenol.
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3.3

Derivatization of Cannabinoids
A common method to protect compounds from decarboxylation is to derivatize them.

Derivatization is the process by which a compound is chemically changed, to produce a new
compound that makes it more suitable for an analytical instrument, or in this case the GC.
Derivatization is useful for research because it prevents decarboxylation, protects hydrophilic
ends, creates better separation and resolution, and helps with the reproducibility of results.
For cannabinoids, silylation is the most common derivatization technique. In silylation, the
silylation reagents react with compounds containing hydroxyl groups by replacing it with an
alkyl silyl group, typically trimethylsilyl. For example, in Figure 27, CBDA is coupled with
bis(trimethylsilyl) acetamide to protect the hydrophilic ends. This resulted in a derivatized
CBDA where the hydroxyl groups were replaced with trimethylsilyl groups.

Figure 27. Derivatization of CBDA using silylation.
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Due to lack of time and resources, CBDA was not derivatized before testing the hemp
oil samples. Therefore, the concentration of CBD detected in the GC included the total
amount of CBD, including those that may have come from CBDA.
3.4

Photodegradation of CBD
Lastly, photodegradation is a prevailing challenge when analyzing CBD via GC [16].

Photodegradation is the alteration of compounds through light. Previous research had shown
CBD to degrade over time due to light and heat [16-19]. Depending on the temperature and
the amount of light CBD is exposed to, it can degrade by 15% in a month [17] and sometimes
even by 50% over a period of two months [19]. This research utilized the GC-MSD to
conduct a degradation study over a period of 5 months on the CBD standard. The CBD
standard (1.000  0.005 mg/mL) was first tested on the GC-MSD in September 2020 and
again in February 2021 (Figure 28).
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Figure 28. Comparison of CBD chromatograms taken in September 2020 and February
2021.
32

Examining the two chromatograms, both detected CBD and produced a corresponding
CBD peak at a retention time of 10.5 min. This peak was confirmed to be CBD by analyzing
the mass spectra (Figure 30) of the peak and identifying it based on the library search
function on the GC-MSD. The GC-MSD library search function matched the fragmentation
pattern of each analyte and correlate it to a known database in the software for an
identification. Not only was it confirmed using the internal database, but it was also further
confirmed to be CBD by comparing the fragmentation pattern to the literature value found on
the NIST Chemistry WebBook. The CBD mass spectra (Figure 29) matched the spectra
provided by NIST Chemistry WebBook (Figure 30) with both spectra having peaks at m/z =
174, 193, 231, 246, and 314.

Figure 29. Mass Spectra of CBD standard from September 2020.
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Figure 30. Mass Spectra of CBD standard. Obtained from NIST WebBook.

Comparing the CBD peaks taken in September and February, the signal intensity was
much stronger in September compared to February, where the signal intensity was about
800,000 au versus 350,000 au, respectively. Furthermore, upon closer examination, there was
a second peak around the 7-min mark in the chromatogram taken in February. This peak
indicated the presence of another compound in the sample and most likely resulted from the
photodegradation of CBD over time. Unfortunately, there was no positive identification of
for compound peak using the library search function in the GC-MSD. Regardless, after this
experiment, it was confirmed that the CBD standard had degraded to some degree. This led to
extra measures taken to ensure the hemp oils to be analyzed were relatively new and had not
been sitting on the shelf for a long period of time.
3.5

Cannabinoid Elution Order
When running the GC, the chromatograms provide two crucial pieces of information:

peak area and retention time. The retention time indicated when the compounds are detected
during the method and the peak area correlates with its concentration. The peak area can vary
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depending on the amount of compounds in the sample, human errors, or instrumental errors.
However, the retention time should remain constant for identical compounds.
Prior to starting the research, it was important to establish the elution order of CBD
and THC in the optimized method. This was done by injecting 1L of each cannabinoid at
1000 ppm into the GC-FID to determine the time frame in which these compounds would
elute. Figure 31 shows the elution order of CBD and THC using the optimized method
previously discussed. The total run time on the GC-FID was 11.5 min and two peaks were
observed at 9.6 and 10.1 min. CBD was identified to elute from the column at 9.6 min and
THC eluted out shortly after at 10.1 min.

Figure 31. The chromatogram containing CBD (9.6 min) and THC (10.1min) on the GCFID.
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3.6

Calibration Curves
An external calibration curve was created for both CBD and THC by creating a series

of dilution at 5 ppm, 10 ppm, 50 ppm, 100 ppm, and 250 ppm for each compound. There
were no interfering peaks observed around the retention time of cannabinoids. The signal
intensities of cannaboids changed between the varying concentrations. However, the
retention time remained consistent. The peak area was calculated by integrating the area
under the peak using the Agilent CDS ChemStation software. Figures 32 and 33 show the
calibration curve for each cannabinoid created with data from the GC-FID.
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Figure 32. The external calibration curve for CBD using GC-FID.
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Figure 33. The external calibration curve for THC using GC-FID.

A comparison between the linearity of the two compounds are shown in Table 5. THC
produced more linear data compared to CBD in the FID. The correlation coefficient (R2)
value for both were above 0.99, which indicates the curve to be well-fitted. These were the
calibration curves used to quantify the total amount of CBD and THC in hemp oil samples.

Table 5. Comparison between the linearity of the calibration curves for CBD and THC.

Cannabinoid

Equation of Line

R2 (FID)

CBD

y=0.011x-0.0123

0.9906

THC

y=0.01x-0.0085

0.9996
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3.7

Hemp Oil Quantitative Results
The main purpose of this experiment was to determine if there were any quantifiable

CBD and THC in five brands of hemp oil while being mindful of all the potential challenges
that are commonly associated with GC analysis.
The O’Rmeas hemp oil had a peak around 9.5 min, which has previously been
identified as CBD (Figure 34). There were no visible peaks at 10 min retention time, which
suggested there were no detectable THC in this hemp oil sample. This was not surprising
since hemp plants typically contain low levels of THC compared to marijuana plants. Hemp
Technique did not show any distinct peaks at both retention time 9.5 and 10 min (Figure 35).
Thus, there were no detectable amount CBD or THC in this hemp oil. Figures 36-38 are the
chromatograms for Hempio, Greenive, and Zatural, respectively. They all had a visible CBD
peak at around 9.5 min and had no detectable THC. In Hempio, the chromatogram was
crowded with significantly more peaks compared to the other hemp oil brands. This could be
due to the fact that Hempio has other ingredients aside from hemp seed oil.
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Figure 34. GC-FID chromatogram of O’Rmeas hemp oil.
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Figure 35. GC-FID chromatogram of Hemp Techniques hemp oil.
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Figure 36. GC-FID chromatogram of Hempio hemp oil.
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Figure 37. GC-FID chromatogram of Greenive hemp oil.
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Figure 38. GC-FID chromatogram of Zatural hemp oil.

Overall, four out of the five brands of hemp oils had a detectable amount of CBD.
None of the hemp oil had any detectable levels of THC present. Each of the hemp oil had a
concentration printed on their products but did not specify what it accounted for. Table 6
shows the calculated CBD amount detected by the GC-FID from the brand with the lowest
quantity to the highest quantity of CBD as well as the quantity printed on the product label.
Zatural had the highest amount of CBD at 13.83 mg, followed by Greenive at 4.39 mg,
Hempio at 0.49 mg, O’Rmeas at 0.14 mg and Hemp Techniques had no detectable CBD. As
shown, the actual CBD amount for every hemp oil sample were significantly lower than what
was printed on the product label. This indicated the amount on the label was not intended to
reflect the CBD amount. The number on the label is most likely indicative of the amount of
hemp oil extract in the bottle, however it does not say specifically.
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Table 6. Calculated CBD amount for each hemp oil sample and the amount printed on their
product label. Amount advertised does not say specify what it alludes to.

3.8

Brand Name

Amount Advertised (mg)

Calculated CBD Amount (mg)

Hemp Techniques

30,000

0

O’Rmeas

35,000

0.14

Hempio

35,000

0.49

Greenive

28,000

4.39

Zatural

300

13.83

GC-MSD of Hemp Oil
Since Zatural was determined to have the highest concentration of CBD, it was ran

through the GC-MSD for further chemical analysis. The GC chromatogram of Zatural
showed one visible peak (Figure 39). which was suspected to be CBD. The mass spectra of
the peak were analyzed and is shown in Figure 40. The parent peak was at m/z 231.2 and a
second peak observed at m/z 207; its proposed molecular structure is shown on Figure 40.
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Figure 39. GC-MSD chromatogram of Zatural hemp oil.

Figure 40. Mass spectrum of the compound at retention time 10.6 min peak (Figure 39). The
suspected major fragment ion at the peak at m/z = 207.1 is shown above.
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IV.

Summary and Conclusions

4.1

Challenges of GC Analysis
The basic principle of gas chromatography is to separate organic compounds in a

solution by injecting it into a sample port to be vaporized at noticeably high heat. CBD and
THC have a relatively high boiling point of 180 °C and 157 °C respectively [20,21].
Subsequently, a high operating temperature is required to separate the cannabinoids from the
sample matrix. Due to the harsh conditions and high temperatures of the GC, it could lead to
a couple potential challenges researchers need to keep in mind when quantifying and
examining CBD. First of all, at high temperatures, septum bleeding can produce ghost peaks
in the chromatogram. Second, it is difficult to quantify CBD without taking into account the
CBD produced through decarboxylation of its precursor, CBDA. Lastly, CBD is susceptible
to degradation and does not have an extensive shelf life. Hence, experiments involving CBD
need to be conducted in a timely manner.
4.2

Examination of CBD and Hemp Oils
All things considered, the GC parameters optimized for this research were able to

detect and identify CBD in commercial hemp oil products. There were no detectable traces of
THC in any of the five hemp oils. This proves the products were in compliance with New
York state and federal regulations. Additionally, hemp products are not legally required to
explicitly state the concentration of CBD. This provides a loophole for companies to print
product labels with a large concentration without specifying what it actually accounts for.
The amount printed on the label most likely referred to the total amount of hemp oil extract in
the bottle. However, to an uninformed consumer, the vagueness the vagueness of the product
label could mislead them into thinking they are buying products containing a generous
amount of CBD. This research supports the previous sentiment as four out of the five
products tested had significantly lower CBD than what was printed on the label. One of them,
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Hemp Techniques, did not even contain any detectable CBD despite the printed label reading
30,000 mg.
Despite the numerous challenges faced in chemical analysis of CBD and THC, it is
paramount to continue developing a reliable GC method to quantify cannabinoids, especially
in the forensic field. Today, marijuana remains illegal on the federal level, however hemp has
been removed from the Controlled Substance Act (CSA). However, law enforcement finds it
difficult to differentiate between the two cannabis plants by sight alone since they are
remarkably similar in appearance. As a result, forensic scientists rely on differentiating the
two plants through chemical analysis. Not only is the GC useful in identifying various
cannabinoids, but it can also accurately quantify how much is present in a sample. This is
crucial since, legally, hemp and marijuana only differ by their THC concentration. Products
containing CBD, such as hempseed oil, are becoming increasingly popular among consumers
to help with anxiety, Post Traumatic Stress Disorder (PTSD), fatigue, muscle aches and many
more. The result of the present study provides a scientific basis for low levels of CBD in
hemp oil products that might suggest otherwise on their product label. By continuing to
develop a dependable protocol for CBD analysis can companies be held accountable for
product transparency, allowing consumers to truly make the most of the numerous health
benefits CBD can provide.
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